Systemic mediators induce fibrogenic effects in normal liver after partial bile duct ligation
- 10 October 2006
- journal article
- Published by Wiley in Liver International
- Vol. 26 (9) , 1138-1147
- https://doi.org/10.1111/j.1478-3231.2006.01346.x
Abstract
Background/Aims: Collagen production by activated hepatic stellate cells (HSCs) is a key event in liver fibrosis, and a number of factors have been characterized that trigger HSC activation and collagen production. However, it remains unclear if these factors act locally at the site of injury or also affect HSCs distant to the site of injury. Methods: A model of partial bile duct ligation (PBDL) in which fibrogenesis can be compared between the injured ligated lobe and the non‐ligated lobe. Results: After PBDL, HSCs showed an increased expression of procollagen type I α1 mRNA and collagen‐reporter gene activity not only in the ligated lobe, but also in the non‐ligated lobe, albeit at a lower level. In contrast, an increase in the number of desmin‐ and α‐smooth muscle actin positive HSCs, and accumulation of inflammatory cells were observed only in the ligated lobe. Although transforming growth factor‐β (TGF‐β) mRNA was increased only in the ligated lobe, Smad2/3 were activated in the ligated and the non‐ligated lobe. These data suggest that the systemic increase in profibrogenic mediators including TGF‐β induces collagen transcription in the uninjured liver. Conclusion: Systemic profibrogenic mediators from the injury site affect the residual non‐injured liver.Keywords
This publication has 25 references indexed in Scilit:
- Vitamin A storage in hepatic stellate cells in the regenerating rat liver: With special reference to zonal heterogeneityThe Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, 2005
- Cell Type-Specific Intervention of Transforming Growth Factor β/Smad Signaling Suppresses Collagen Gene Expression and Hepatic Fibrosis in MiceGastroenterology, 2005
- A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populationsHepatology, 2004
- Role of hepatic stellate cell/hepatocyte interaction and activation of hepatic stellate cells in the early phase of liver regeneration in the ratJournal of Hepatology, 2004
- Transforming growth factor-β and connective tissue growth factor: key cytokines in scleroderma pathogenesisCurrent Opinion in Rheumatology, 2001
- Interactions between Hepatic Stellate Cells and the Immune SystemSeminars in Liver Disease, 2001
- Hepatic Stellate Cells as a Target for the Treatment of Liver FibrosisSeminars in Liver Disease, 2001
- Possible involvement of reactive oxygen species in D‐galactosamine–induced sensitization against tumor necrosis factor‐α–induced hepatocyte apoptosisJournal of Cellular Physiology, 2001
- The hepatic stellate (Ito) cell: its role in human liver diseaseVirchows Archiv, 1997
- Liver transplantation: Viral hepatitisHepatology, 1995